Evaluating real-world COVID-19 vaccine effectiveness using a test-negative case-control design

被引：7

作者：

Reynolds, Matthew W. ^{[1
]}

Secora, Alex ^{[1
]}

Joules, Alice ^{[1
]}

Albert, Lisa ^{[1
]}

Brinkley, Emma ^{[1
]}

Kwon, Tom ^{[1
]}

Mack, Christina ^{[1
]}

Toovey, Stephen ^{[2
]}

Dreyer, Nancy A. ^{[1
]}

机构：

[1] IQVIA Real World Solutions, 201 Broadway, Cambridge, MA 02139 USA

[2] Pegasus Res, Neuschwaendistr 6, CH-6390 Engelberg, Switzerland

来源：

JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH | 2022年 / 11卷 / 16期

关键词：

COVID-19; patient-reported outcomes; person-generated health data; SARS-CoV-2; symptoms; test-negative design; vaccines; PREVENTING SARS-COV-2 INFECTION; 8 US LOCATIONS; FRONTLINE WORKERS; PEOPLE;

D O I：

10.2217/cer-2022-0069

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

Aim: It is important to assess if clinical trial efficacy translates into real-world effectiveness for COVID-19 vaccines. Materials & methods: We conducted a modified test-negative design (TND) to evaluate the real-world effectiveness of three COVID-19 vaccines. We defined cases in two ways: self-reported COVID-19-positive tests, and self-reported positive tests with >= 1 moderate/severe COVID-19 symptom. Results: Any vaccination was associated with a 95% reduction in subsequently reporting a positive COVID-19 test, and a 71% reduction in reporting a positive test and >= 1 moderate/severe symptom. Conclusion: We observed high effectiveness across all three marketed vaccines, both for self-reported positive COVID-19 tests and moderate/severe COVID-19 symptoms. This innovative TND approach can be implemented in future COVID-19 vaccine and treatment real-world effectiveness studies. Clinicaltrials.gov identifier: .

引用

页码：1161 / 1172

页数：12

共 31 条

[11] Estimating Influenza Vaccine Effectiveness With the Test-Negative Design Using Alternative Control Groups: A Systematic Review and Meta-Analysis [J].

Feng, Shuo ;

Cowling, Benjamin J. ;

Kelly, Heath ;

Sullivan, Sheena G. .

AMERICAN JOURNAL OF EPIDEMIOLOGY, 2018, 187 (02) :389-397

[12] Effectiveness of COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Frontline Workers Before and During B.1.617.2 (Delta) Variant Predominance - Eight US Locations, December 2020-August 2021 [J].

Fowlkes, Ashley ;

Gaglani, Manjusha ;

Groover, Kimberly ;

Thiese, Matthew S. ;

Tyner, Harmony ;

Ellingson, Katherine .

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2021, 70 (34) :1167-1169

[13] Basic principles of test-negative design in evaluating influenza vaccine effectiveness [J].

Fukushima, Wakaba ;

Hirota, Yoshio .

VACCINE, 2017, 35 (36) :4796-4800

[14] Real-world effectiveness of BNT162b2 mRNA vaccine: a meta-analysis of large observational studies [J].

Kow, Chia Siang ;

Hasan, Syed Shahzad .

INFLAMMOPHARMACOLOGY, 2021, 29 (04) :1075-1090

[15] Postlicensure Evaluation of COVID-19 Vaccines [J].

Patel, Manish M. ;

Jackson, Michael L. ;

Ferdinands, Jill .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (19) :1939-1940

[16] Evaluation of post-introduction COVID-19 vaccine effectiveness: Summary of interim guidance of the World Health Organization [J].

Patel, Minal K. ;

Bergeri, Isabel ;

Bresee, Joseph S. ;

Cowling, Benjamin J. ;

Crowcroft, Natasha S. ;

Fahmy, Kamal ;

Hirve, Siddhivinayak ;

Kang, Gagandeep ;

Katz, Mark A. ;

Lanata, Claudio F. ;

Jackson, Maina L'Azou ;

Joshi, Sudhir ;

Lipsitch, Marc ;

Mwenda, Jason M. ;

Nogareda, Francisco ;

Orenstein, Walter A. ;

Ortiz, Justin R. ;

Pebody, Richard ;

Schrag, Stephanie J. ;

Smith, Peter G. ;

Srikantiah, Padmini ;

Subissi, Lorenzo ;

Valenciano, Marta ;

Vaughn, David W. ;

Verani, Jennifer R. ;

Wilder-Smith, Annelies ;

Feikin, Daniel R. .

VACCINE, 2021, 39 (30) :4013-4024

[17]

Pilishvili T, 2021, MMWR-MORBID MORTAL W, V70, P753, DOI [10.15585/mmwr.mm7020e2, 10.15585/mmwr.mm7020e2externalicon]

[18] Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine [J].

Polack, Fernando P. ;

Thomas, Stephen J. ;

Kitchin, Nicholas ;

Absalon, Judith ;

Gurtman, Alejandra ;

Lockhart, Stephen ;

Perez, John L. ;

Perez Marc, Gonzalo ;

Moreira, Edson D. ;

Zerbini, Cristiano ;

Bailey, Ruth ;

Swanson, Kena A. ;

Roychoudhury, Satrajit ;

Koury, Kenneth ;

Li, Ping ;

Kalina, Warren V. ;

Cooper, David ;

Frenck, Robert W., Jr. ;

Hammitt, Laura L. ;

Tureci, Ozlem ;

Nell, Haylene ;

Schaefer, Axel ;

Unal, Serhat ;

Tresnan, Dina B. ;

Mather, Susan ;

Dormitzer, Philip R. ;

Sahin, Ugur ;

Jansen, Kathrin U. ;

Gruber, William C. .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (27) :2603-2615

[19] Protecting vulnerable patients with inherited anaemias from unnecessary death during the COVID-19 pandemic [J].

Roy, Noemi B. A. ;

Telfer, Paul ;

Eleftheriou, Perla ;

de la Fuente, Josu ;

Drasar, Emma ;

Shah, Farrukh ;

Roberts, David ;

Atoyebi, Wale ;

Trompeter, Sara ;

Layton, D. Mark ;

Lugthart, Sanne ;

Stuart-Smith, Sara ;

Chakravorty, Subarna ;

Wright, Josh ;

Porter, John ;

Inusa, Baba ;

Howard, Jo .

BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 (04) :635-639

[20] Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19 [J].

Sadoff, Jerald ;

Gray, Glenda ;

Vandebosch, An ;

Cardenas, Vicky ;

Shukarev, Georgi ;

Grinsztejn, Beatriz ;

Goepfert, Paul A. ;

Truyers, Carla ;

Fennema, Hein ;

Spiessens, Bart ;

Offergeld, Kim ;

Scheper, Gert ;

Taylor, Kimberly L. ;

Robb, Merlin L. ;

Treanor, John ;

Barouch, Dan H. ;

Stoddard, Jeffrey ;

Ryser, Martin F. ;

Marovich, Mary A. ;

Neuzil, Kathleen M. ;

Corey, Lawrence ;

Cauwenberghs, Nancy ;

Tanner, Tamzin ;

Hardt, Karin ;

Ruiz-Guinazu, Javier ;

Le Gars, Mathieu ;

Schuitemaker, Hanneke ;

Van Hoof, Johan ;

Struyf, Frank ;

Douoguih, Macaya .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (23) :2187-2201

← 1 2 3 4 →